Genesis Energy
GEL
12.34
-0.13
-1.04%
Genesis Energy
US · GEL
#2897 by market cap
Listed 1970
12.34
-0.13
-1.04%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Genesis Energy (GEL.US) will release its financial report before the market opens on November 5.Market Newswire · 2026/10/31
-
Company notice
Sol-Gel Technologies | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc.SEC · 2026/9/4
-
Rating change
LifeSci Capital Maintains Sol-Gel Technologies(SLGL.US) With Buy Rating, Maintains Target Price $184Market Newswire · 2026/8/18
-
Company notice
C'BON COSMETICS: Both the Sea and the bright impression. With W ingredient* and W concentration*, the targeted, rich gel serum "Seeboon AC W Shot Serum" has arrived.JPX · 2026/9/24
-
Rating change
Mizuho Securities Maintains Sol-Gel Technologies(SLGL.US) With Buy Rating, Maintains Target Price $285Market Newswire · 2026/8/21
-
Sol-Gel Intends to Retain Full U.S. Comml Rights and to Commercialize SGT-610 Through a Cost-Effective Model SLGLDow Jones · 2026/11/12
-
Zhaok Ophthalmology-B (06622.HK) has received marketing approval from the National Medical Products Administration for Jingyouling® (Cyclosporine Eye Gel), an innovative drug independently developed by the company.Gelonghui Finance · 2026/11/13
-
Company notice
Sol-Gel Technologies | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc.SEC · 2026/9/10
-
Rating change
HC Wainwright & Co. Reiterates Buy on Sol-Gel Technologies, Maintains $110 Price TargetBenzinga · 2026/10/19
-
Rating change
LifeSci Capital Maintains Sol-Gel Technologies(SLGL.US) With Buy Rating, Maintains Target Price $195Market Newswire · 2026/8/23
-
Rating change
RBC Capital Maintains Genesis Energy(GEL.US) With Buy Rating, Cuts Target Price to $18Market Newswire · 2026/7/22
-
Zhaoko Ophthalmology-B (06622): The company's independently developed innovative drug, Jingyouling® (Cyclosporine Ophthalmic Gel), has received marketing approval from the National Medical Products Administration.Zhitong Finance · 2026/11/13
-
Company notice
Kowa: Regarding the sale of walking aids equipped with "αGEL" material grips, under a partnership with Taika Co., Ltd.JPX · 2026/9/14
-
Rating change
LifeSci Capital Maintains Sol-Gel Technologies(SLGL.US) With Buy Rating, Raises Target Price to $195Market Newswire · 2026/8/20
-
Rating change
Cantor Fitzgerald Initiates Sol-Gel Technologies(SLGL.US) With Buy Rating, Announces Target Price $200Market Newswire · 2026/10/14
-
Wells Fargo Initiates Genesis Energy(GEL.US) With Buy Rating, Announces Target Price $18Market Newswire · 2026/11/11
-
Rating change
H.C. Wainwright Maintains Sol-Gel Technologies(SLGL.US) With Buy Rating, Maintains Target Price $110Market Newswire · 2026/10/19
-
Company notice
Sol-Gel Technologies | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc.SEC · 2026/9/15
-
Rating change
Sol-Gel Technologies Price Target Maintained With a $110.00/Share by HC Wainwright & Co.Dow Jones · 2026/10/19
-
Rating change
RBC Capital Maintains Genesis Energy(GEL.US) With Buy Rating, Cuts Target Price to $17Market Newswire · 2026/10/13
-
Rating change
Wells Fargo Initiates Genesis Energy(GEL.US) With Buy Rating, Announces Target Price $18Market Newswire · 2026/8/14
-
Rating change
Mizuho Securities Initiates Sol-Gel Technologies(SLGL.US) With Buy Rating, Announces Target Price $285Market Newswire · 2026/6/24
-
Aqua Label's multi-functional gel cream, now available in a larger volume for extended use, is being released in a limited quantity with special packaging.Shiseido · 2026/10/20
-
Rating change
TD Cowen Initiates Sol-Gel Technologies(SLGL.US) With Buy RatingMarket Newswire · 2026/5/29
-
Beiteli (301697.SZ): Thermal conductive gel samples have been delivered to leading optical module clients, but sales have not yet commenced.Gelonghui Finance · 2026/9/7
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Genesis Energy discussion 0 comments